Company intelligence / Profile preview

Baylis Medical Company

Montreal, Quebec, Canada

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Baylis Medical Company is a leading innovator in left heart access solutions, with its RF NRG and VersaCross platforms having been used in over one million procedures globally[2][6]. The technologies are clinically proven to enhance safety, efficacy, and efficiency in transseptal puncture and other cardiovascular interventions[2].

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Boston Scientific (acquiring company; expanded commercial reach and R&D)

Beyond the preview

Go deeper on Baylis Medical Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baylis Medical Company.

Explore the full profile